(Q34567518)

3 August 2017

title

Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database (English)

1 reference

3 August 2017

0 references

1 reference

Jean Lachaine

1

1 reference

3 August 2017

Linnette Yen

series ordinal

2

1 reference

3 August 2017

Catherine Beauchemin

series ordinal

3

1 reference

3 August 2017

Paul Hodgkins

series ordinal

4

1 reference

3 August 2017

publication date

30 January 2013

1 reference

3 August 2017

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

page(s)

23

1 reference

Creative Commons Attribution 2.0 Generic

3 August 2017

copyright license

start time

30 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

One-year investigator-blind randomized multicenter trial comparing Asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Impact of persistence with infliximab on hospitalizations in ulcerative colitis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Systematic review: the costs of ulcerative colitis in Western countries

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Inflammatory bowel disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

The geoepidemiology of autoimmune intestinal diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Environmental factors affecting inflammatory bowel disease: have we made progress?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Systematic review: adherence issues in the treatment of ulcerative colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Current concept of pathophysiological understanding and natural course of ulcerative colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

A chronic disease score from automated pharmacy data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570329

Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-23

Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-23

A checklist for medication compliance and persistence studies using retrospective databases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-23

Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-23

Predictors of medication adherence in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-23

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-23

An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group

21 January 2018

1 reference

12 December 2020

Nonadherence in inflammatory bowel disease: results of factor analysis

1 reference

12 December 2020

Increasing patient adherence to gastroenterology treatment and prevention regimens

1 reference

12 December 2020

Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-13-23

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference